Hangzhou Dalton BioSciences, Ltd.

Hangzhou Dalton BioSciences, Ltd.

Zhejiang,China

Hangzhou Dalton BioSciences, Ltd.

Zhejiang,China

Hangzhou Dalton BioSciences, Ltd.
favorite supplier

Hangzhou Dalton BioSciences, Ltd.

Zhejiang,China

Scan QR code

Access to mobile station

Clear All
Alternate Text

High Risk Human Papillomavirus (HPV) Genotyping System

FOB Price : Get a Price/Quote

Min.Order : 2000 Piece(s)

Certification : CFDA,CE,MDSAP

Brand Name : DALTONbio

Payment Terms : T/T

share :

product information

  • brand name : DALTONbio

  • certification : CFDA,CE,MDSAP

  • min.order : 2000 Piece(s)

  • warranty : 24 months

  • payment terms : T/T

  • Packaging : 48 tests/kit, 96 tests/kit

  • Specification : 16×13×12 cm

  • place of origin : Zhejiang

product description

[Product Components]
Automatic Hybrid Capture System (HB-104C\ HB-304C)
Chemiluminescence Immunoassay Analyzer (CS-SA301C)
96 well Hybridization microplate with lid
Specimen collection tube screw caps
Disposable cervical sampling brush
Specimen Preservation Solution
Cell Preservation Solution
Antigen Retrieval Buffer
Wash Buffer

The DH3 is an in vitro nucleic hybridization assay, using a new generation hybrid capture technology for the qualitative detection of 14 high-risk types of human papillomavirus (HPV) in cervical specimens. The HPV types detected by the assay are the high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. The DH3 can distinguish between HPV16/18 and the other 12 pooled HR-HPV genotypes. The test can be used for one of the following indications:
1. The test can be used for patients with ASC-US (atypical squamous cells of undetermined significance) cervical cytology results to assess the presence or absence of high-risk HPV types. This information may be used to determine the need for referral to colposcopy. The results of this test are not intended to prevent women from proceeding to colposcopy.
2. The test can be used with Pap to adjunctively screen to assess the presence or absence of high-risk HPV types. This information, together with the physician's assessment of cytology history, other risk factors, and professional guidelines, may be used to guide patient management.
3. The test can be used as a first-line primary cervical cancer screening test to detect high risk HPV. Women who test negative for high-risk HPV types by this test should be followed in accordance with the physician's assessment of screening and medical history, other risk factors, and professional guidelines. Women who test positive for HPV 16/18 should be referred to colposcopy. Women who test high-risk HPV positive and HPV 16/18 negative by the test (indicating a positive for the other 12 high risk HPV types) should be evaluated by cervical cytology to determine the need for referral to colposcopy.

People who viewed this also viewed

  • p16/Ki-67 Dual Staining Test System

    FOB Price :

    Min.Order : 2000 Piece(s)

  • High Risk Human Papillomavirus (HPV) Screening System

    FOB Price :

    Min.Order : 2000 Piece(s)

  • High Risk Human Papillomavirus (HPV) Genotyping System

    FOB Price :

    Min.Order : 2000 Piece(s)

Hangzhou Dalton BioSciences, Ltd.

Ordinary verified

Business Type Manufacturer

Country / Region Zhejiang,China

Main Products Diagnostic Equipment, In vitro Diagnosis Reagents, Laboratory Equipment

Main Markets

High Risk Human Papillomavirus (HPV) Genotyping System
share :

product information

product description

[Product Components]
Automatic Hybrid Capture System (HB-104C\ HB-304C)
Chemiluminescence Immunoassay Analyzer (CS-SA301C)
96 well Hybridization microplate with lid
Specimen collection tube screw caps
Disposable cervical sampling brush
Specimen Preservation Solution
Cell Preservation Solution
Antigen Retrieval Buffer
Wash Buffer

The DH3 is an in vitro nucleic hybridization assay, using a new generation hybrid capture technology for the qualitative detection of 14 high-risk types of human papillomavirus (HPV) in cervical specimens. The HPV types detected by the assay are the high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. The DH3 can distinguish between HPV16/18 and the other 12 pooled HR-HPV genotypes. The test can be used for one of the following indications:
1. The test can be used for patients with ASC-US (atypical squamous cells of undetermined significance) cervical cytology results to assess the presence or absence of high-risk HPV types. This information may be used to determine the need for referral to colposcopy. The results of this test are not intended to prevent women from proceeding to colposcopy.
2. The test can be used with Pap to adjunctively screen to assess the presence or absence of high-risk HPV types. This information, together with the physician's assessment of cytology history, other risk factors, and professional guidelines, may be used to guide patient management.
3. The test can be used as a first-line primary cervical cancer screening test to detect high risk HPV. Women who test negative for high-risk HPV types by this test should be followed in accordance with the physician's assessment of screening and medical history, other risk factors, and professional guidelines. Women who test positive for HPV 16/18 should be referred to colposcopy. Women who test high-risk HPV positive and HPV 16/18 negative by the test (indicating a positive for the other 12 high risk HPV types) should be evaluated by cervical cytology to determine the need for referral to colposcopy.

Recommend

Join Free

Create New Account

Leave your contact information for the suppliers. If you're our member, Please Sign In to use your account information.

Sign in